{"id":42413,"date":"2018-09-19T11:10:45","date_gmt":"2018-09-19T09:10:45","guid":{"rendered":"https:\/\/newserver.fyb.de\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/"},"modified":"2018-09-19T11:10:45","modified_gmt":"2018-09-19T09:10:45","slug":"shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/","title":{"rendered":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson"},"content":{"rendered":"<p>Tuebingen\/Tuttlingen \u2014 <strong>SHS Gesell\u00adschaft<\/strong> <strong>fuer Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment<\/strong>, <strong>MBG Baden-W\u00fcrt\u00adtem\u00adberg<\/strong> and <strong>VC Fonds BW<\/strong> announ\u00adced that Emer\u00adging Implant Tech\u00adno\u00adlo\u00adgies GmbH (EIT), a manu\u00adfac\u00adtu\u00adrer of 3D-prin\u00adted tita\u00adnium inter\u00adbody implants for spinal fusion surgery, has been acqui\u00adred by John\u00adson &amp; John\u00adson Medi\u00adcal GmbH. SHS became EIT\u2019s lead inves\u00adtor in Septem\u00adber 2016. Since then the Tuebin\u00adgen based medtech specia\u00adlist has subse\u00adquently supported the company\u2019s growth stra\u00adtegy. The finan\u00adcial terms of the deal are undisclosed.<\/p>\n<p>\u201cSHS\u2019s objec\u00adtive was to support EIT on their path to increased growth. This includes the deve\u00adlo\u00adp\u00adment of the company\u2019s inno\u00adva\u00adtive product port\u00adfo\u00adlio as well as ente\u00adring new count\u00adries. We\u2019re deligh\u00adted to have had such a successful part\u00adner\u00adship with EIT and its employees. We look forward to see EIT\u2019s unique products and Cellu\u00adlar Tita\u00adnium\u00ae tech\u00adno\u00adlogy bene\u00adfit from DePuy Synthes global commer\u00adcial infra\u00adstruc\u00adture and products. We wish EIT all the best in their future deve\u00adlo\u00adp\u00adment and trust that the company is in good hands with its new owners\u201d, says Dr. Bern\u00adhard Schirm\u00aders, Mana\u00adging Part\u00adner of SHS, lead inves\u00adtor with&nbsp;EIT.<\/p>\n<p>Gunt\u00admar Eisen, Foun\u00adder and Chief Execu\u00adtive Offi\u00adcer of EIT says: \u201cThe EIT team is passio\u00adnate about the work we do every day to deve\u00adlop 3D-prin\u00adted tita\u00adnium spinal implants. We are proud of what we have achie\u00adved with the EIT cellu\u00adlar tita\u00adnium cages and we are exci\u00adted to bring this inno\u00adva\u00adtive tech\u00adno\u00adlogy to DePuy Synthes, and to custo\u00admers around the&nbsp;world.\u201d<\/p>\n<p>To learn more about the announce\u00adment, click here: https:\/\/www.prnewswire.com\/news-releases\/johnson\u2013johnson-medical-gmbh-acquires-emerging-implant-technologies-gmbh-to-enhance-global-offering-of-interbody-spine-implants-300710822.html<\/p>\n<p><strong>About SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment&nbsp;mbH<\/strong><br>\nGermany (Tuebin\u00adgen) based SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment was foun\u00added in 1993 and invests in medi\u00adcal tech\u00adno\u00adlogy and life science compa\u00adnies with a focus on expan\u00adsion finan\u00adcing, chan\u00adges in share\u00adhol\u00adder struc\u00adtures and succes\u00adsor situa\u00adtions in the DACH-region, Bene\u00adlux-count\u00adries and Scan\u00addi\u00adna\u00advia. Medi\u00adcal device invest\u00adments made by the sector specia\u00adlist SHS include for exam\u00adple German company phenox, which specia\u00adli\u00adzes in tech\u00adno\u00adlo\u00adgies for the treat\u00adment of neuro\u00advas\u00adcu\u00adlar dise\u00ada\u00adses, Austrian reha\u00adbi\u00adli\u00adta\u00adtion robo\u00adtics company Tyro\u00admo\u00adtion, and the Swiss manu\u00adfac\u00adtu\u00adrer of cardio\u00adlogy products SIS Medi\u00adcal. In its fifth fund\u2019s first closing in July 2018 SHS has recei\u00adved capi\u00adtal commit\u00adments of over \u20ac90 million. Inves\u00adtors can invest in SHS V until final closing (target \u20ac150 million). The company invests up to 30 million euros in equity. Rein\u00adhilde Spat\u00adscheck, Dr. Bern\u00adhard Schirm\u00aders, Huber\u00adtus Leon\u00adhardt and Uwe Stein\u00adba\u00adcher are the Mana\u00adging Part\u00adners at&nbsp;SHS.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tuebingen\/Tuttlingen \u2014 SHS Gesell\u00adschaft fuer Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment, MBG Baden-W\u00fcrt\u00ad\u00adte\u00adm\u00ad\u00adberg and VC Fonds BW announ\u00adced that Emer\u00adging Implant Tech\u00adno\u00adlo\u00adgies GmbH (EIT), a manu\u00adfac\u00adtu\u00adrer of 3D-prin\u00ad\u00adted tita\u00adnium inter\u00adbody implants for spinal fusion surgery, has been acqui\u00adred by John\u00adson &amp; John\u00adson Medi\u00adcal GmbH. SHS became EIT\u2019s lead inves\u00adtor in Septem\u00adber 2016. Since then the Tuebin\u00adgen based medtech specia\u00adlist&nbsp;has&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42427,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42413","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-private-equity-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Tuebingen\/Tuttlingen \u2014 SHS Gesell\u00adschaft fuer Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment, MBG Baden-W\u00fcrt\u00adtem\u00adberg and VC Fonds BW announ\u00adced that Emer\u00adging Implant Tech\u00adno\u00adlo\u00adgies GmbH (EIT), a manu\u00adfac\u00adtu\u00adrer of 3D-prin\u00adted tita\u00adnium inter\u00adbody implants for spinal fusion surgery, has been acqui\u00adred by John\u00adson &amp; John\u00adson Medi\u00adcal GmbH. SHS became EIT\u2019s lead inves\u00adtor in Septem\u00adber 2016. Since then the Tuebin\u00adgen based medtech specia\u00adlist has [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-19T09:10:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson\",\"datePublished\":\"2018-09-19T09:10:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\"},\"wordCount\":399,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\",\"url\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\",\"name\":\"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png\",\"datePublished\":\"2018-09-19T09:10:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png\",\"width\":300,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/","og_locale":"en_US","og_type":"article","og_title":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook","og_description":"Tuebingen\/Tuttlingen \u2014 SHS Gesell\u00adschaft fuer Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment, MBG Baden-W\u00fcrt\u00adtem\u00adberg and VC Fonds BW announ\u00adced that Emer\u00adging Implant Tech\u00adno\u00adlo\u00adgies GmbH (EIT), a manu\u00adfac\u00adtu\u00adrer of 3D-prin\u00adted tita\u00adnium inter\u00adbody implants for spinal fusion surgery, has been acqui\u00adred by John\u00adson &amp; John\u00adson Medi\u00adcal GmbH. SHS became EIT\u2019s lead inves\u00adtor in Septem\u00adber 2016. Since then the Tuebin\u00adgen based medtech specia\u00adlist has [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2018-09-19T09:10:45+00:00","og_image":[{"width":300,"height":200,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png","type":"image\/png"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson","datePublished":"2018-09-19T09:10:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/"},"wordCount":399,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/","url":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/","name":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png","datePublished":"2018-09-19T09:10:45+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/09\/a-shs_pe-300x200.png","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/shs-sells-its-shares-in-emerging-implant-technologies-to-johnson-johnson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"SHS sells its shares in Emerging Implant Technologies to Johnson &amp; Johnson"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42413"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42413\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42427"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}